166 related articles for article (PubMed ID: 26980026)
21. Biopsy-proven cerebellar metastasis from a malignant mixed mullerian tumor (MMMT) of the uterus: case report.
Kim JK; Lee SK; Myong NH; Kang YD
Eur J Gynaecol Oncol; 2009; 30(2):196-8. PubMed ID: 19480254
[TBL] [Abstract][Full Text] [Related]
22. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
[TBL] [Abstract][Full Text] [Related]
23. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
Duman BB; Kara IO; Günaldi M; Ercolak V
Arch Gynecol Obstet; 2011 Jun; 283(6):1363-8. PubMed ID: 21298439
[TBL] [Abstract][Full Text] [Related]
24. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
25. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.
Wen YH; Brogi E; Hasanovic A; Ladanyi M; Soslow RA; Chitale D; Shia J; Moreira AL
Mod Pathol; 2013 Sep; 26(9):1197-203. PubMed ID: 23599147
[TBL] [Abstract][Full Text] [Related]
27. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
28. Malignant mixed müllerian tumors of the ovary.
Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916
[TBL] [Abstract][Full Text] [Related]
29. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
30. Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review.
Ma CJ; Yang SF; Huang CC; Chai CY; Cheng KI; Tsai EM; Wang JY
Eur J Gynaecol Oncol; 2008; 29(3):289-93. PubMed ID: 18592799
[TBL] [Abstract][Full Text] [Related]
31. Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association.
Arora P; Rao S; Khurana N; Talwar D; Tanwar R
J Cancer Res Ther; 2011; 7(1):88-91. PubMed ID: 21546752
[TBL] [Abstract][Full Text] [Related]
32. Loss of p16 in recurrent malignant mixed müllerian tumors of the uterus.
Robinson-Bennett B; Belch RZ; Han AC
Int J Gynecol Cancer; 2006; 16(3):1354-7. PubMed ID: 16803529
[TBL] [Abstract][Full Text] [Related]
33. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
34. Heparin-binding epidermal growth factor-like growth factor and transforming growth factor-alpha in human non-small cell lung cancers.
Chong IW; Lin SR; Lin MS; Huang MS; Tsai MS; Hwang JJ
J Formos Med Assoc; 1997 Aug; 96(8):579-85. PubMed ID: 9290266
[TBL] [Abstract][Full Text] [Related]
35. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
[TBL] [Abstract][Full Text] [Related]
36. Malignant mixed Müllerian tumor with an extensive squamous-cell carcinomatous component: a potential pitfall in liquid-based cervical cytology.
Bongiovanni M; Vitale VA; Grassi P; Mazzucchelli L
Acta Cytol; 2014; 58(4):413-8. PubMed ID: 25059755
[TBL] [Abstract][Full Text] [Related]
37. Malignant mixed Mullerian tumor of the uterine cervix with neuroendocrine differentiation.
Ribeiro-Silva A; Novello-Vilar A; Cunha-Mercante AM; De Angelo Andrade LA
Int J Gynecol Cancer; 2002; 12(2):223-7. PubMed ID: 11975686
[TBL] [Abstract][Full Text] [Related]
38. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
Buza N; Tavassoli FA
Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
[TBL] [Abstract][Full Text] [Related]
40. Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature.
Garamvoelgyi E; Guillou L; Gebhard S; Salmeron M; Seematter RJ; Hadji MH
Cancer; 1994 Aug; 74(3):854-63. PubMed ID: 7518735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
